The Pharmacology Center

Filter Your Results

 

News

 

One-Year Outcomes With Intracoronary Abciximab Evaluated in Diabetic Patients Undergoing Primary PCI

August 16, 2016 -- In diabetic patients with ST-segment elevation myocardial infarction (STEMI), the administration of intracoronary abciximab -- compared with the intravenous…

RE-VECTO Global Program Will Capture Clinical Practice Data on Boehringer Ingelheim’s Praxbind

August 15, 2016 -- Boehringer Ingelheim Pharmaceuticals, Inc. announced the initiation of its global RE-VECTO program, which will capture data on Praxbind (idarucizu…

Empagliflozin Supported by FDA Advisory Committee With 12-11 Vote

June 30, 2016 -- Boehringer Ingelheim and Eli Lilly and Company announced this week that the US Food and Drug Administration (FDA) Advisory Committee voted 12 -- 11 that subst…

Medicure Applies to FDA for Approval of New Aggrastat Format

May 11, 2016 -- Medicure Inc. announced that it has submitted an application to the US Food and Drug Administration (FDA) for the introduction of a new “bolus vial&rdquo…

PROMETHEUS Compares Women and Men Treated With PCI for ACS

May 6, 2016 -- The Society for Cardiovascular Angiography and Interventions (SCAI) announced the presentation of the PROMETHEUS study, showing that women younger than 55 years…

BRAVO 3 Compares Two Anticoagulants for Gender-Based TAVR Outcomes

May 9, 2016 -- Findings from the BRAVO 3 study -- which assessed the impact of using different anticoagulation medications on men and women who have undergone transcatheter ao…

Hospital System’s Bleeding Risk Assessment Study Demonstrates Reduced Events and Costs

May 4, 2016 -- The Society for Cardiovascular Angiography and Interventions (SCAI) announced that the largest risk-directed study by a national hospital system demonstrated a …

Study Supports Using Crushed Prasugrel Tablets in Patients With STEMI Undergoing PPCI

April 26, 2016 -- CRUSH study investigators have concluded that crushed prasugrel tablets lead to faster drug absorption, and consequently, more prompt and potent antipla…

 

advertisement

2018 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.